Vedere Bio

Closed

Bringing vision back to life.

Cambridge, United States · Founded 2020

Employees
1–10
Founded
2020
Business Model
B2B

About

Vedere Bio II, Inc. was a Cambridge, Massachusetts-based biotechnology company developing next-generation ocular gene therapies for vision restoration and preservation in patients with vision loss due to photoreceptor death. Founded in 2020 by leaders of the original Vedere Bio (acquired by Novartis in 2020), the company raised $77M in Series A funding before winding down operations in April 2023.

Summary

Vedere Bio is a Biotech company based in Cambridge, United States, founded in 2020.

Similar Companies